A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INTRACORONARY NITROGLYCERIN